I think startups can prevail in terms of business model and not just technology.
Look at Uber, Uber has an app, but the real issue in Uber is creating a marketplace, managing a brand, managing relationships with drivers, fighting the taxi companies, etc.
Innovations in how health care is organized and delivered are very possible.
As for food and water I'll say that the case for vegetarian and veganism is often overstated. Out here in upstate New York we have plenty of water and plenty of hillsides that are good for grazing and not for tilling. In other places the situation is different, but in some places animal agriculture is part of the solution and not the problem.
I think both the single payer and pension arguments miss the fact that the US is at a hub of a system. Inflated drug prices in the US finance drug development and cheaper drug prices in the ROW. Similarly, what a government run pension fund can attain in another country is unrelated to what one can attain in the US.
I agree with the part about stagnant real incomes, which meshes with the rising cost of health insurance, housing and college, but I don't think professional pension fund managers do that much better than individuals in the long term. They may avoid stupid mistakes like selling all of your shares in the winter of 2008-2009, but the real advantage pensions have is that they can borrow from peter to pay paul, at least in the short term.
Look at Uber, Uber has an app, but the real issue in Uber is creating a marketplace, managing a brand, managing relationships with drivers, fighting the taxi companies, etc.
Innovations in how health care is organized and delivered are very possible.
As for food and water I'll say that the case for vegetarian and veganism is often overstated. Out here in upstate New York we have plenty of water and plenty of hillsides that are good for grazing and not for tilling. In other places the situation is different, but in some places animal agriculture is part of the solution and not the problem.
I think both the single payer and pension arguments miss the fact that the US is at a hub of a system. Inflated drug prices in the US finance drug development and cheaper drug prices in the ROW. Similarly, what a government run pension fund can attain in another country is unrelated to what one can attain in the US.
I agree with the part about stagnant real incomes, which meshes with the rising cost of health insurance, housing and college, but I don't think professional pension fund managers do that much better than individuals in the long term. They may avoid stupid mistakes like selling all of your shares in the winter of 2008-2009, but the real advantage pensions have is that they can borrow from peter to pay paul, at least in the short term.